A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma
- 1 January 2002
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (6) , 779-783
- https://doi.org/10.1016/s0959-8049(01)00428-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Advances in the Treatment of Malignant Pleural MesotheliomaChest, 1999
- A phase II study of gemcitabine in patients with malignant pleural mesotheliomaCancer, 1999
- The European mesothelioma epidemicBritish Journal of Cancer, 1999
- Malignant pleural mesotheliomaEuropean Respiratory Journal, 1998
- Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group BChest, 1998
- Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.Journal of Clinical Oncology, 1998
- Etoposide in malignant pleural mesothelioma: Two phase II trials of the EORTC lung cancer cooperative groupEuropean Journal Of Cancer, 1997
- Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative GroupBritish Journal of Cancer, 1996
- Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.Journal of Clinical Oncology, 1992
- Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1991